{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:02:16Z","timestamp":1791223336680,"version":"4.1.0"},"reference-count":102,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":764,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1111\/all.12184","type":"journal-article","created":{"date-parts":[[2013,7,29]],"date-time":"2013-07-29T09:59:38Z","timestamp":1375091978000},"page":"974-982","source":"Crossref","is-referenced-by-count":271,"title":["Immunology of atopic eczema: overcoming the Th1\/Th2 paradigm"],"prefix":"10.1111","volume":"68","author":[{"given":"K.","family":"Eyerich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Novak","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy; University of Bonn Medical Center; Bonn; Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,7,29]]},"reference":[{"key":"10.1111\/all.12184-BIB0001|all12184-cit-0001","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2009.11.008","article-title":"An update on the genetics of atopic dermatitis: scratching the surface in 2009","volume":"125","author":"Barnes","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"5 Pt 1","key":"10.1111\/all.12184-BIB0002|all12184-cit-0002","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0190-9622(93)70099-F","article-title":"Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample","volume":"28","author":"Schultz Larsen","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/all.12184-BIB0003|all12184-cit-0003","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1067\/mai.2001.119408","article-title":"Concordance and interrelationship of atopic diseases and markers of allergic sensitization among adult female twins","volume":"108","author":"Strachan","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0004|all12184-cit-0004","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jaci.2007.08.067","article-title":"Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data","volume":"120","author":"Baurecht","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0005|all12184-cit-0005","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/ng.358","article-title":"A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming","volume":"41","author":"Fallon","year":"2009","journal-title":"Nat Genet"},{"key":"10.1111\/all.12184-BIB0006|all12184-cit-0006","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/sj.jid.5701208","article-title":"Filaggrin expression in oral, nasal, and esophageal mucosa","volume":"128","author":"Benedetto","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1111\/all.12184-BIB0007|all12184-cit-0007","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jaci.2008.02.039","article-title":"Filaggrin variants confer susceptibility to asthma","volume":"121","author":"McLean","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0008|all12184-cit-0008","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1371\/journal.pmed.0050131","article-title":"Gene-environment interaction in the onset of eczema in infancy: filaggrin loss-of-function mutations enhanced by neonatal cat exposure","volume":"5","author":"Bisgaard","year":"2008","journal-title":"PLoS Med"},{"key":"10.1111\/all.12184-BIB0009|all12184-cit-0009","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/j.1398-9995.2009.02080.x","article-title":"Filaggrin mutations in the onset of eczema, sensitization, asthma, hay fever and the interaction with cat exposure","volume":"64","author":"Schuttelaar","year":"2009","journal-title":"Allergy"},{"key":"10.1111\/all.12184-BIB0010|all12184-cit-0010","doi-asserted-by":"crossref","first-page":"pii","DOI":"10.4172\/2155-9899.1000110","article-title":"Th2 cytokines and atopic dermatitis","volume":"2","author":"Brandt","year":"2011","journal-title":"J Clin Cell Immunol"},{"key":"10.1111\/all.12184-BIB0011|all12184-cit-0011","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000331871","article-title":"IL-25 induces both inflammation and skin barrier dysfunction in atopic dermatitis","volume":"96","author":"Deleuran","year":"2012","journal-title":"Chem Immunol Allergy"},{"key":"10.1111\/all.12184-BIB0012|all12184-cit-0012","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/all.12051","article-title":"Histamine suppresses epidermal keratinocyte differentiation and impairs skin barrier function in a human skin model","volume":"68","author":"Gschwandtner","year":"2013","journal-title":"Allergy"},{"issue":"3 Suppl 2","key":"10.1111\/all.12184-BIB0013|all12184-cit-0013","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1016\/j.jaci.2009.07.012","article-title":"Cytokine modulation of atopic dermatitis filaggrin skin expression","volume":"124","author":"Howell","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0014|all12184-cit-0014","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1038\/jid.2008.74","article-title":"Th2 cytokines act on S100\/A11 to downregulate keratinocyte differentiation","volume":"128","author":"Howell","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1111\/all.12184-BIB0015|all12184-cit-0015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/1523-1747.ep12321078","article-title":"Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients","volume":"105","author":"Grewe","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1111\/all.12184-BIB0016|all12184-cit-0016","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1600-0625.2009.00980.x","article-title":"Comparative in situ topoproteome analysis reveals differences in patch test-induced eczema: cytotoxicity-dominated nickel versus pleiotrope pollen reaction","volume":"19","author":"Eyerich","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1111\/all.12184-BIB0017|all12184-cit-0017","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jaci.2012.03.006","article-title":"TH2 cytokines increase kallikrein 7 expression and function in patients with atopic dermatitis","volume":"130","author":"Morizane","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0018|all12184-cit-0018","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.jaci.2010.12.1124","article-title":"Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities","volume":"127","author":"Suarez-Farinas","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0019|all12184-cit-0019","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1056\/NEJMoa1104200","article-title":"Mutual antagonism of T cells causing psoriasis and atopic eczema","volume":"365","author":"Eyerich","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/all.12184-BIB0020|all12184-cit-0020","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0190-9622(95)91336-X","article-title":"Disease concomitance in psoriasis","volume":"32","author":"Henseler","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/all.12184-BIB0021|all12184-cit-0021","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0091-6749(95)70172-9","article-title":"Atopy patch test with different vehicles and allergen concentrations: an approach to standardization","volume":"95","author":"Darsow","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0022|all12184-cit-0022","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jaci.2011.05.042","article-title":"Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response","volume":"128","author":"Tintle","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0023|all12184-cit-0023","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMra074081","article-title":"Atopic dermatitis","volume":"358","author":"Bieber","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/all.12184-BIB0024|all12184-cit-0024","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000109290","article-title":"Pollen grains induce a rapid and biphasic eczematous immune response in atopic eczema patients","volume":"145","author":"Eyerich","year":"2008","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1111\/all.12184-BIB0025|all12184-cit-0025","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMra1011040","article-title":"Filaggrin mutations associated with skin and allergic diseases","volume":"365","author":"Irvine","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/all.12184-BIB0026|all12184-cit-0026","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ng728","article-title":"Gene polymorphism in Netherton and common atopic disease","volume":"29","author":"Walley","year":"2001","journal-title":"Nat Genet"},{"key":"10.1111\/all.12184-BIB0027|all12184-cit-0027","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1038\/sj.jid.5701190","article-title":"Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel","volume":"128","author":"Novak","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1111\/all.12184-BIB0028|all12184-cit-0028","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1398-9995.2011.02545.x","article-title":"Functional effects of interleukin 31 in human primary keratinocytes","volume":"66","author":"Kasraie","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.12184-BIB0029|all12184-cit-0029","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1398-9995.2011.02710.x","article-title":"Macrophages from patients with atopic dermatitis show a reduced CXCL10 expression in response to staphylococcal alpha-toxin","volume":"67","author":"Kasraie","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/all.12184-BIB0030|all12184-cit-0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev.immunol.25.022106.141718","article-title":"TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation","volume":"25","author":"Liu","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"10.1111\/all.12184-BIB0031|all12184-cit-0031","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJMoa021481","article-title":"Endogenous antimicrobial peptides and skin infections in atopic dermatitis","volume":"347","author":"Ong","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/all.12184-BIB0032|all12184-cit-0032","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaci.2008.10.031","article-title":"IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response","volume":"123","author":"Eyerich","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0033|all12184-cit-0033","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jaci.2011.05.043","article-title":"Reduced IFN-gamma receptor expression and attenuated IFN-gamma response by dendritic cells in patients with atopic dermatitis","volume":"128","author":"Gros","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0034|all12184-cit-0034","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jaci.2011.02.010","article-title":"Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-gamma response","volume":"127","author":"Leung","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"3 Pt 1","key":"10.1111\/all.12184-BIB0035|all12184-cit-0035","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/jid.2011.374","article-title":"Genetic variants in interferon regulatory factor 2 (IRF2) are associated with atopic dermatitis and eczema herpeticum","volume":"132","author":"Gao","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1111\/all.12184-BIB0036|all12184-cit-0036","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1398-9995.2011.02767.x","article-title":"Cord blood Tregs with stable FOXP3 expression are influenced by prenatal environment and associated with atopic dermatitis at the age of one year","volume":"67","author":"Hinz","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/all.12184-BIB0037|all12184-cit-0037","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1398-9995.2008.01922.x","article-title":"New insights into the mechanism and management of allergic diseases: atopic dermatitis","volume":"64","author":"Novak","year":"2009","journal-title":"Allergy"},{"key":"10.1111\/all.12184-BIB0038|all12184-cit-0038","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/all.12109","article-title":"FcepsilonRI stimulation promotes the differentiation of histamine receptor 1-expressing inflammatory macrophages","volume":"68","author":"Novak","year":"2013","journal-title":"Allergy"},{"key":"10.1111\/all.12184-BIB0039|all12184-cit-0039","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1398-9995.2010.02524.x","article-title":"Tetraspanins CD9 and CD81 are molecular partners of trimeric FcvarepsilonRI on human antigen-presenting cells","volume":"66","author":"Peng","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.12184-BIB0040|all12184-cit-0040","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jaci.2009.07.004","article-title":"Expression of chemokines and chemokine receptors in lesional and nonlesional upper skin of patients with atopic dermatitis","volume":"124","author":"Gros","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0041|all12184-cit-0041","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaci.2008.05.005","article-title":"Tacrolimus and TGF-beta act synergistically on the generation of Langerhans cells","volume":"122","author":"Kwiek","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0042|all12184-cit-0042","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/all.12090","article-title":"Aberrant dendritic cell function conditions Th2-cell polarization in allergic rhinitis","volume":"68","author":"Pilette","year":"2013","journal-title":"Allergy"},{"key":"10.1111\/all.12184-BIB0043|all12184-cit-0043","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaci.2011.05.016","article-title":"Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets","volume":"128","author":"Fujita","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0044|all12184-cit-0044","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nature07548","article-title":"Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein","volume":"457","author":"Trompette","year":"2009","journal-title":"Nature"},{"key":"10.1111\/all.12184-BIB0045|all12184-cit-0045","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jcp.21764","article-title":"Der p2 activates airway smooth muscle cells in a TLR2\/MyD88-dependent manner to induce an inflammatory response","volume":"220","author":"Chiou","year":"2009","journal-title":"J Cell Physiol"},{"key":"10.1111\/all.12184-BIB0046|all12184-cit-0046","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/ni.1919","article-title":"Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel","volume":"11","author":"Schmidt","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1111\/all.12184-BIB0047|all12184-cit-0047","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/j.1398-9995.2011.02652.x","article-title":"Mechanisms of chemical-induced innate immunity in allergic contact dermatitis","volume":"66","author":"Martin","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.12184-BIB0048|all12184-cit-0048","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1084\/jem.20041065","article-title":"Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization","volume":"201","author":"Traidl-Hoffmann","year":"2005","journal-title":"J Exp Med"},{"key":"10.1111\/all.12184-BIB0049|all12184-cit-0049","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1067\/mai.2002.124655","article-title":"Lipid mediators from pollen act as chemoattractants and activators of polymorphonuclear granulocytes","volume":"109","author":"Traidl-Hoffmann","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0050|all12184-cit-0050","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/jid.2010.419","article-title":"Evidence for non-allergic mast cell activation in pollen-associated inflammation","volume":"131","author":"Metz","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1111\/all.12184-BIB0051|all12184-cit-0051","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1398-9995.2012.02857.x","article-title":"Skin thymic stromal lymphopoietin promotes airway sensitization to inhalant house dust mites leading to allergic asthma in mice","volume":"67","author":"Jiang","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/all.12184-BIB0052|all12184-cit-0052","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jaci.2010.08.041","article-title":"Mechanical injury polarizes skin dendritic cells to elicit a T(H)2 response by inducing cutaneous thymic stromal lymphopoietin expression","volume":"126","author":"Oyoshi","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0053|all12184-cit-0053","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jaci.2008.10.008","article-title":"Cytokine milieu modulates release of thymic stromal lymphopoietin from human keratinocytes stimulated with double-stranded RNA","volume":"123","author":"Kinoshita","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0054|all12184-cit-0054","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jaci.2010.09.002","article-title":"Staphylococcus aureus membrane and diacylated lipopeptide induce thymic stromal lymphopoietin in keratinocytes through the Toll-like receptor 2-Toll-like receptor 6 pathway","volume":"126","author":"Vu","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0055|all12184-cit-0055","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2012.07.012","article-title":"Progressive activation of T(H)2\/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis","volume":"130","author":"Gittler","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0056|all12184-cit-0056","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jaci.2009.03.041","article-title":"IL-22-producing \u201cT22\u201d T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells","volume":"123","author":"Nograles","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0057|all12184-cit-0057","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1684\/ejd.2012.1854","article-title":"Differential in situ expression of IL-17 in skin diseases","volume":"22","author":"Fischer-Stabauer","year":"2012","journal-title":"Eur J Dermatol"},{"key":"10.1111\/all.12184-BIB0058|all12184-cit-0058","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1101\/gr.131029.111","article-title":"Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis","volume":"22","author":"Kong","year":"2012","journal-title":"Genome Res"},{"key":"10.1111\/all.12184-BIB0059|all12184-cit-0059","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/all.12145","article-title":"TLR2 down-regulates FcepsilonRI and its transcription factor PU.1 in human Langerhans cells","volume":"68","author":"Herrmann","year":"2013","journal-title":"Allergy"},{"key":"10.1111\/all.12184-BIB0060|all12184-cit-0060","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jaad.2010.03.044","article-title":"Superantigens in dermatology","volume":"64","author":"Macias","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/all.12184-BIB0061|all12184-cit-0061","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jaci.2010.07.041","article-title":"Staphylococcal exotoxins are strong inducers of IL-22: a potential role in atopic dermatitis","volume":"126","author":"Niebuhr","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0062|all12184-cit-0062","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaci.2005.10.033","article-title":"IL-31: a new link between T cells and pruritus in atopic skin inflammation","volume":"117","author":"Sonkoly","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0063|all12184-cit-0063","first-page":"3573","article-title":"Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling","volume":"119","author":"Eyerich","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1111\/all.12184-BIB0064|all12184-cit-0064","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.it.2010.06.004","article-title":"IL-17 and IL-22: siblings, not twins","volume":"31","author":"Eyerich","year":"2010","journal-title":"Trends Immunol"},{"key":"10.1111\/all.12184-BIB0065|all12184-cit-0065","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/000155500459303","article-title":"IgE antibodies to Malassezia furfur, M. sympodialis and Pityrosporum orbiculare in patients with atopic dermatitis, seborrheic eczema or pityriasis versicolor, and identification of respective allergens","volume":"80","author":"Mayser","year":"2000","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/all.12184-BIB0066|all12184-cit-0066","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1067\/mai.2000.105528","article-title":"Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis","volume":"105","author":"Bunikowski","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0067|all12184-cit-0067","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1046\/j.1398-9995.2003.00330.x","article-title":"IgE-binding components of cultured human keratinocytes in atopic eczema\/dermatitis syndrome and their crossreactivity with Malassezia furfur","volume":"59","author":"Kortekangas-Savolainen","year":"2004","journal-title":"Allergy"},{"key":"10.1111\/all.12184-BIB0068|all12184-cit-0068","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jaci.2009.05.015","article-title":"Exploring the repertoire of IgE-binding self-antigens associated with atopic eczema","volume":"124","author":"Zeller","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0069|all12184-cit-0069","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1084\/jem.184.1.265","article-title":"Humoral and cell-mediated autoimmunity in allergy to Aspergillus fumigatus","volume":"184","author":"Crameri","year":"1996","journal-title":"J Exp Med"},{"key":"10.1111\/all.12184-BIB0070|all12184-cit-0070","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1365-2133.2010.10090.x","article-title":"The role of T-cell reactivity towards the autoantigen alpha-NAC in atopic dermatitis","volume":"164","author":"Heratizadeh","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/all.12184-BIB0071|all12184-cit-0071","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.4049\/jimmunol.0901767","article-title":"IL-17 amplifies human contact hypersensitivity by licensing hapten nonspecific Th1 cells to kill autologous keratinocytes","volume":"184","author":"Pennino","year":"2010","journal-title":"J Immunol"},{"key":"10.1111\/all.12184-BIB0072|all12184-cit-0072","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/ACI.0b013e328354e540","article-title":"Evidences of efficacy of allergen immunotherapy in atopic dermatitis: an updated review","volume":"12","author":"Compalati","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0073|all12184-cit-0073","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2500\/aap.2008.29.3160","article-title":"Efficacy of omalizumab in the treatment of atopic dermatitis: a pilot study","volume":"29","author":"Sheinkopf","year":"2008","journal-title":"Allergy Asthma Proc"},{"key":"10.1111\/all.12184-BIB0074|all12184-cit-0074","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jaci.2007.08.060","article-title":"Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels","volume":"120","author":"Belloni","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0075|all12184-cit-0075","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaci.2010.07.042","article-title":"Improvement of treatment-refractory atopic dermatitis by immunoadsorption: a pilot study","volume":"127","author":"Kasperkiewicz","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0076|all12184-cit-0076","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4168\/aair.2011.3.2.89","article-title":"Long-term efficacy of intravenous immunoglobulin therapy for moderate to severe childhood atopic dermatitis","volume":"3","author":"Jee","year":"2011","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1111\/all.12184-BIB0077|all12184-cit-0077","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jaci.2007.11.016","article-title":"Anti-CD20 (rituximab) treatment improves atopic eczema","volume":"121","author":"Simon","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0078|all12184-cit-0078","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jaci.2008.03.007","article-title":"Anti-CD20 (rituximab) treatment for atopic eczema","volume":"121","author":"Sediva","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0079|all12184-cit-0079","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1398-9995.2005.00791.x","article-title":"Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis","volume":"60","author":"Oldhoff","year":"2005","journal-title":"Allergy"},{"key":"10.1111\/all.12184-BIB0080|all12184-cit-0080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0923-1811(03)00132-4","article-title":"Effective treatment of pruritus in atopic dermatitis using H1 antihistamines (second-generation antihistamines): changes in blood histamine and tryptase levels","volume":"33","author":"Imaizumi","year":"2003","journal-title":"J Dermatol Sci"},{"key":"10.1111\/all.12184-BIB0081|all12184-cit-0081","first-page":"1286","article-title":"Pitrakinra, a dual IL-4\/IL-13 antagonist for the potential treatment of asthma and eczema","volume":"11","author":"Antoniu","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1111\/all.12184-BIB0082|all12184-cit-0082","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jaci.2012.02.005","article-title":"Oral application of bacterial lysate in infancy decreases the risk of atopic dermatitis in children with 1 atopic parent in a randomized, placebo-controlled trial","volume":"129","author":"Lau","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0083|all12184-cit-0083","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaci.2012.02.043","article-title":"Development of atopic dermatitis according to age of onset and association with early-life exposures","volume":"130","author":"Roduit","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"3 Pt 1","key":"10.1111\/all.12184-BIB0084|all12184-cit-0084","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jaad.2004.11.022","article-title":"Infliximab in the treatment of moderate to severe atopic dermatitis","volume":"52","author":"Jacobi","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/all.12184-BIB0085|all12184-cit-0085","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jaad.2005.03.013","article-title":"Etanercept is minimally effective in 2 children with atopic dermatitis","volume":"53","author":"Buka","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/all.12184-BIB0086|all12184-cit-0086","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-4632.2011.05195.x","article-title":"Treatment of severe refractory adult atopic dermatitis with ustekinumab","volume":"51","author":"Puya","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1111\/all.12184-BIB0087|all12184-cit-0087","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jaci.2011.09.009","article-title":"Interrupting IL-6-receptor signaling improves atopic dermatitis but associates with bacterial superinfection","volume":"128","author":"Navarini","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0088|all12184-cit-0088","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/all.12112","article-title":"Characterization of different courses of atopic dermatitis in adolescent and adult patients","volume":"68","author":"Garmhausen","year":"2013","journal-title":"Allergy"},{"key":"10.1111\/all.12184-BIB0089|all12184-cit-0089","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/all.12049","article-title":"Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine","volume":"67","author":"Bieber","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/all.12184-BIB0090|all12184-cit-0090","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1398-9995.2012.02845.x","article-title":"Atopic dermatitis: a candidate for disease-modifying strategy","volume":"67","author":"Bieber","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/all.12184-BIB0091|all12184-cit-0091","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1398-9995.2011.02571.x","article-title":"Atopic dermatitis - from new pathophysiologic insights to individualized therapy","volume":"66","author":"Novak","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.12184-BIB0092|all12184-cit-0092","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jaad.2005.02.014","article-title":"Failure of omalizumab for treatment of severe adult atopic dermatitis","volume":"53","author":"Krathen","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/all.12184-BIB0093|all12184-cit-0093","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaad.2005.09.030","article-title":"Treatment of recalcitrant atopic dermatitis with omalizumab","volume":"54","author":"Lane","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/all.12184-BIB0094|all12184-cit-0094","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1610-0387.2010.07497.x","article-title":"Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course - a randomized, placebo-controlled and double blind pilot study","volume":"8","author":"Heil","year":"2010","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/all.12184-BIB0095|all12184-cit-0095","first-page":"341","article-title":"A phase 2, open-label, investigator-initiated study to evaluate the safety and efficacy of apremilast in subjects with recalcitrant allergic contact or atopic dermatitis","volume":"11","author":"Volf","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/all.12184-BIB0096|all12184-cit-0096","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/archdermatol.2012.812","article-title":"A pilot study of an oral phosphodiesterase inhibitor (apremilast) for atopic dermatitis in adults","volume":"148","author":"Samrao","year":"2012","journal-title":"Arch Dermatol"},{"issue":"2 Pt 1","key":"10.1111\/all.12184-BIB0097|all12184-cit-0097","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0190-9622(93)70026-P","article-title":"Recombinant interferon gamma therapy for atopic dermatitis","volume":"28","author":"Hanifin","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/all.12184-BIB0098|all12184-cit-0098","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1067\/mjd.2000.104793","article-title":"Clinical improvement and immunohistochemical findings in severe atopic dermatitis treated with interferon gamma","volume":"42","author":"Jang","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/all.12184-BIB0099|all12184-cit-0099","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jaad.2008.02.007","article-title":"Alefacept for moderate to severe atopic dermatitis: a pilot study in adults","volume":"58","author":"Moul","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/all.12184-BIB0100|all12184-cit-0100","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jaci.2008.06.010","article-title":"Alefacept (lymphocyte function-associated molecule 3\/IgG fusion protein) treatment for atopic eczema","volume":"122","author":"Simon","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12184-BIB0101|all12184-cit-0101","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1468-3083.2009.03202.x","article-title":"Efalizumab for severe refractory atopic eczema: retrospective study on 11 cases","volume":"24","author":"Ibler","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/all.12184-BIB0102|all12184-cit-0102","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jaad.2006.08.031","article-title":"Efalizumab for severe atopic dermatitis: a pilot study in adults","volume":"56","author":"Takiguchi","year":"2007","journal-title":"J Am Acad Dermatol"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fall.12184","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T14:42:58Z","timestamp":1715784178000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/all.12184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,29]]},"references-count":102,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"URL":"https:\/\/doi.org\/10.1111\/all.12184","relation":{},"ISSN":["0105-4538"],"issn-type":[{"value":"0105-4538","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7,29]]}}}